CompletedNot Applicable

Modulation of Upper Limb Spasticity Post-Stroke

Saudi Arabia38 participantsStarted 2020-10-01

Plain-language summary

Stroke is one of the commonest causes of severe disability in adults. Stroke often results in spasticity and motor impairments in the upper limb. Permanent upper extremity impairments can lead to limitations in activities of daily living, social participation, and quality of life. Spasticity may obscure motor learning ability after stroke. Spasticity control is one of the main aims of most therapists in the rehabilitation process for patients with chronic stroke. Traditional approaches for managing spasticity may not be enough for gaining satisfactory results. Virtual reality-based therapy is one of the most innovative and developments in rehabilitation technology. It could be effective in accelerating motor recovery and modulating spasticity for the involved upper limbs. The purpose of this study was to examine the impact of virtual reality-based therapy on upper limb spasticity and motor functions in patients post-stroke.

Who can participate

Age range50 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: The inclusion criteria were as follow: * Participants were diagnosed as chronic stroke patients. * Participants were selected to be in the spastic phase, 6-24 months following a first stroke. * The degree of spasticity in the affected upper limbs, was ranged between grades (1, 1+\&2) according to Modified Ashworth Scale. * Participants were all between 50 and 60 years old, of both sexes. * Participants were cognitively able to understand and follow instructions. * Participants had the ability to extend their wrist joints at least 20° and ﬁngers 10° from full ﬂexion. This range allowed participants to engage easily in performing a designed functional program. Exclusion Criteria: The exclusion criteria were as follow: * Participants who were with any orthopaedic condition or fixed deformity that interfere with the upper limb functions. * Participants who were with spasticity more than score 2 according to the Modified Ashworth Scale. * Participants who had cognitive or perceptual problems. * Participants with surgical interference for the upper limb and spine within the previous 2 years. * Participants with seizures, visual impairments, or auditory problems. * Participants who had shoulder pain on a visual analogue scale of \> 6/10. * Participants who had Botulinum Toxin in the upper extremity musculature six months before baseline assessment.

What they're measuring

Change in the score of The Wolf Motor Function Test (test that assess the change in upper extremity motor ability)

Timeframe: [Data was collected at baseline, and 12 weeks after intervention commencement.] (i.e. Difference between The Wolf Motor Function Test Score at both baseline and completion of 12 weeks of intervention)

Change in the score of The Action Research Arm Test (test that assess the change in upper extremity functions)

Timeframe: [Data was collected at baseline, and 12 weeks after intervention commencement.] (i.e. Difference between The Action Research Arm Test Score at both baseline and completion of 12 weeks of intervention)

Change in the Modified Ashworth Scale (scale that assess the change in muscle tone)

Timeframe: [Data was collected at baseline, and 12 weeks after intervention commencement.] (i.e. Difference between the degree of muscle tone at both baseline and completion of 12 weeks of intervention)

Trial details

NCT IDNCT05069480

SponsorUmm Al-Qura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-30

View on ClinicalTrials.gov More Spasticity as Sequela of Stroke trials